vTv Therapeutics Inc. - (VTVT): Price and Financial Metrics

vTv Therapeutics Inc. - (VTVT)

Today's Latest Price: $2.02 USD

0.02 (-0.98%)

Updated Sep 17 6:55pm

Add VTVT to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 232 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

VTVT Stock Summary

  • VTVT's price/sales ratio is 6,240.32; that's higher than the P/S ratio of 99.79% of US stocks.
  • Over the past twelve months, VTVT has reported earnings growth of 264.7%, putting it ahead of 94.91% of US stocks in our set.
  • Revenue growth over the past 12 months for vTv Therapeutics Inc comes in at -99.78%, a number that bests only 0.5% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to vTv Therapeutics Inc are VNRX, AUPH, RVNC, ADVM, and AIMT.
  • Visit VTVT's SEC page to see the company's official filings. To visit the company's web site, go to www.vtvtherapeutics.com.
VTVT Daily Price Range
VTVT 52-Week Price Range

VTVT Stock Price Chart Technical Analysis Charts

VTVT Price/Volume Stats

Current price $2.02 52-week high $4.23
Prev. close $2.04 52-week low $1.35
Day low $1.95 Volume 243,000
Day high $2.09 Avg. volume 587,740
50-day MA $2.25 Dividend yield N/A
200-day MA $2.30 Market Cap 143.53M

vTv Therapeutics Inc. - (VTVT) Company Bio

vTv Therapeutics Inc., a biopharmaceutical company, discovers, develops, and sells orally administered small molecule drug candidates worldwide. The company was founded in 2015 and is based in High Point, North Carolina.

VTVT Latest News Stream

Event/Time News Detail
Loading, please wait...

VTVT Latest Social Stream

Loading social stream, please wait...

View Full VTVT Social Stream

Latest VTVT News From Around the Web

Below are the latest news stories about vTv Therapeutics Inc that investors may wish to consider to help them evaluate VTVT as an investment opportunity.

An In-Depth Look At vTv Therapeutics

Pity is the most agreeable feeling among those who have little pride and no prospects of great conquests."― Friedrich Nietzsche Today, we take an in depth look at a small developmental company that comes up from time to time in comments. The stock also sees large purchases of stock by...

The Insiders Forum on Seeking Alpha | September 16, 2020

vTv Therapeutics Announces 2020 Second Quarter Financial Results and Update

HIGH POINT, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the second quarter ended…

GlobeNewswire | August 3, 2020

vTv Therapeutics to Present Additional Clinical Data from the STEADFAST Study of Azeliragon at the Virtual Alzheimer's Association International Conference

HIGH POINT, N.C., July 27, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) today announced that the Company will present at the upcoming 2020 Alzheimer's Association International Conference (AAIC), held virtually, July 27–31, 2020. The poster presentation will highlight additional analyses of the clinical data from the STEADFAST Study of azeliragon showing the relative contribution of the effects on individual test items, as well as on the higher level cognitive and/or function domains, to the potential benefits of azeliragon on the Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-cog) and Clinical Dementia Rating Scale (CDR), tools used by doctors to assess someone’s Alzheimer’s disease.Details of the virtual presentation are below:Presentation Title: E...

Yahoo | July 27, 2020

vTv Therapeutics' TTP399 successful in mid-stage type 1 diabetes study

VTv Therapeutics (VTVT) is up 45% premarket on the heels of results from the Phase 2 Simplici-T1 study evaluating TTP399 as an adjunct to insulin therapy in adults with type 1 diabetes.The results demonstrate that TTP399, a once-a-day pill, reduces HbA1c and improves time in range, without increasing hypoglycemia or any signal for adverse...

Seeking Alpha | June 15, 2020

Is vTv Therapeutics Inc (VTVT) A Good Stock To Buy?

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each […]

Yahoo | June 4, 2020

Read More 'VTVT' Stories Here

VTVT Price Returns

1-mo -10.62%
3-mo -24.06%
6-mo 18.13%
1-year 27.04%
3-year -66.72%
5-year -73.28%
YTD 18.82%
2019 -35.85%
2018 -55.91%
2017 24.43%
2016 -29.07%
2015 N/A

Continue Researching VTVT

Want to see what other sources are saying about vTv Therapeutics Inc's financials and stock price? Try the links below:

vTv Therapeutics Inc (VTVT) Stock Price | Nasdaq
vTv Therapeutics Inc (VTVT) Stock Quote, History and News - Yahoo Finance
vTv Therapeutics Inc (VTVT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8261 seconds.